244 studies found for:    Open Studies | "Parasitic Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Parasitic Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
2 Recruiting Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
Condition: Parasitic Disease
Intervention:
3 Recruiting Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Conditions: Asthma;   Eosinophilia;   Helminthiasis;   Hypersensitivity;   Parasitic Disease
Intervention:
4 Available Compassionate Use of Triclabendazole for the Treatment of Parasites (Prior to FDA Approval; Expanded Access Program)
Condition: Parasitic Disease
Intervention: Drug: Triclabendazole
5 Unknown  Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158
Conditions: Trypanosomiasis;   Trypanosomiasis, African;   Protozoan Infections;   Parasitic Diseases
Interventions: Drug: SCYX-7158;   Drug: Placebo
6 Not yet recruiting Efficacy and Safety Study for PIOLIN® Shampoo
Condition: PEDICULOSIS
Interventions: Drug: PIOLIN®;   Drug: NEDAX
7 Recruiting Spillover Effects of Water, Sanitation, and Hygiene Interventions on Child Health
Conditions: Helminthiasis;   Diarrhea;   Respiratory Infection
Intervention: Behavioral: Combined water, sanitation, and hygiene
8 Not yet recruiting Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children
Condition: Scabies
Interventions: Drug: Ivermectin;   Drug: Permethrin
9 Unknown  Babesia Testing in Blood Donors
Condition: Transfusion Transmitted Babesiosis
Intervention: Biological: B.microti diagnostic blood tests
10 Unknown  Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Conditions: Cryptosporidium;   Cryptosporidiosis;   Waterborne Disease;   Diarrheal Disease
Intervention: Other: Ceramic water filter
11 Unknown  Treatment of Asymptomatic Toxocariasis With Albendazole in Children
Condition: Asymptomatic Toxocariasis
Interventions: Drug: Albendazole;   Drug: Placebo
12 Recruiting Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Condition: Congenital Toxoplasmosis
Interventions: Procedure: reducing treatment to 3 months;   Procedure: registered length of treatment
13 Not yet recruiting Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole
Condition: Neurocysticercosis
Interventions: Drug: Oxfendazole;   Drug: Placebo
14 Unknown  Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children
Condition: Cerebral Malaria
Interventions: Drug: inhaled nitric oxide;   Drug: Placebo
15 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine
16 Not yet recruiting Single Ascending Dose Safety Study of Oxfendazole
Condition: Tenia Solium Infection
Interventions: Drug: oxfendazole;   Drug: placebo
17 Not yet recruiting Severe and Cerebral Malaria Investigated Through Host Metabolomics
Condition: Severe Malaria
Intervention: Other: Observation
18 Unknown  Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients
Condition: Neurocysticercosis
Interventions: Drug: Albendazole;   Drug: Dexamethasone;   Drug: Omeprazole
19 Recruiting Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT
Condition: Neurocysticercosis
Interventions: Drug: 7 days of albendazole  15 mg/kg/day;   Drug: 28 days of albendazole 15 mg/kg/day
20 Recruiting A Dose-Escalation, Safety and Feasibility Study of Enteral LVT for Seizure Control in Pediatric CM
Conditions: Seizure;   Epilepsy;   Cerebral Malaria
Interventions: Drug: Oral Levetiracetam;   Drug: Standard AED

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years